Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:11 am Sale | 2021-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | BALYASNY ASSET MANAGEMENT LLC | 0 0.000% | -4,408,952 (Position Closed) | Filing History |
| 2021-12-03 06:09 am Purchase | 2021-11-23 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | BALYASNY ASSET MANAGEMENT LLC | 4,408,952 5.670% | 4,408,952 (New Position) | Filing History |
| 2021-02-12 3:36 pm Sale | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | EcoR1 Capital LLC | 0 0.000% | -3,627,597 (Position Closed) | Filing History |
| 2021-02-12 10:01 am Purchase | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | RTW INVESTMENTS LLC | 7,253,857 9.670% | 1,379,628 (+23.49%) | Filing History |
| 2021-02-04 11:40 am Purchase | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | WELLINGTON MANAGEMENT CO LLP | 4,317,623 5.750% | 3,648,932 (+545.68%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | BLACKROCK INC BLK | 6,034,729 8.000% | 1,601,639 (+36.13%) | Filing History |
| 2020-12-14 5:25 pm Sale | 2020-12-10 | 13D | Dicerna Pharmaceuticals, Inc. DRNA | Bain Capital Life Sciences Fund L.P. | 2,786,247 3.700% | -904,556 (-24.51%) | Filing History |